Showing 61 - 80 results of 824 for search '"interferon"', query time: 0.05s Refine Results
  1. 61
  2. 62

    Interferon Treatment of Hepatitis C Reinfection after Liver Transplantation: A Meta-Analysis by Yaqin Chen, Gang Wu, Hongmin Zhang, Hua Xu, Hong Li, Ling Chen, Yixuan Yang, Peng Hu, Dazhi Zhang, Hong Ren, Huaidong Hu

    Published 2015-01-01
    “…This meta-analysis was performed to compare the effectiveness and risk of adverse events of interferon-based therapy with no treatment after liver transplantation. …”
    Get full text
    Article
  3. 63

    Tracheal Papilloma Treated with Cryotherapy and Interferon-α: A Case Report and Review of the Literature by Fatma Yıldırım, Murat Türk, Sedat Demircan, Nalan Akyürek, Ahmet Selim Yurdakul

    Published 2015-01-01
    “…Patient was treated with interferon-α (IFN-α) and he showed no recurrence at the 8th month of his therapy.…”
    Get full text
    Article
  4. 64

    Interferon‐β–Induced Injury During Pediatric Muscle Differentiation: Insight Into Juvenile Dermatomyositis Pathogenesis by Lauren T. Covert, Alaa Osman, George A. Truskey

    Published 2025-01-01
    “…Objective Juvenile dermatomyositis (JDM) involves up‐regulated type I interferons (IFNs), including IFNβ, yet pathologic mechanisms remain poorly understood. …”
    Get full text
    Article
  5. 65

    The Effects of Alpha Interferon on the Development of Autoimmune Thyroiditis in the NOD H2h4 Mouse by Yael Oppenheim, Grace Kim, Yoshiyuki Ban, Pamela Unger, Erlinda Concepcion, Takao Ando, Yaron Tomer

    Published 2003-01-01
    “…Alpha interferon (αIFN) therapy is known to induce thyroid autoimmunity in up to 40% of patients. …”
    Get full text
    Article
  6. 66

    Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy by Bassem Refaat, Ahmed Mohamed Ashshi, Adel Galal El-Shemi, Esam Azhar

    Published 2015-01-01
    “…Pegylated-interferon-α based therapy for the treatment of chronic hepatitis C (CHC) is considered suboptimal as not all patients respond to the treatment and it is associated with several side effects that could lead to dose reduction and/or termination of therapy. …”
    Get full text
    Article
  7. 67
  8. 68

    Newer Clinical Strategies for Combining Interferon and Cytotoxic Agents Against Solid Tumours and Hematological Malignancies by Scott Wadler

    Published 1994-01-01
    “…The role of interferons in the treatment of cancer continues to evolve. …”
    Get full text
    Article
  9. 69

    Onset of Celiac Disease after Treatment of Chronic Hepatitis C with Interferon Based Triple Therapy by Amandeep Singh, Nayere Zaeri, Immanuel K. Ho

    Published 2015-01-01
    “…Patients treated with interferon (IFN) based therapies may develop exacerbation of autoimmune disease. …”
    Get full text
    Article
  10. 70
  11. 71

    Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1 by Adriano Boasso

    Published 2013-01-01
    “…Type I interferon (IFN-I) play a critical role in the innate immune response against viral infections. …”
    Get full text
    Article
  12. 72

    In vitro interleukin 4 and interferon-gamma production by mononuclear cells from atopic dermatitis patients by Serge Well, Friedhelm Diel

    Published 1993-01-01
    “…In order to elucidate further the possible role of specific cytokines in the pathogenesis of atopic dermatitis (AD) the in vitro production of interleukin 4 (IL-4) and interferon-gamma (IFN-γ) in patients with severe atopic dermatitis (n = 4) was compared with that in a group of non-atopic healthy controls. …”
    Get full text
    Article
  13. 73
  14. 74
  15. 75

    Russian interferon <i>α</i>-2b drug in the treatment of chronic hepatitis C by N. B. Kovaleva

    Published 2014-08-01
    “…To study efficacy and safety of domestic recombinant interferon α-2b Altevir® in combination to ribavirin in previously untreated patients with chronic hepatitis C (CHC).Material and methods. …”
    Get full text
    Article
  16. 76

    Blockade Effects of Anti-Interferon- (IFN-) γ Autoantibodies on IFN-γ-Regulated Antimicrobial Immunity by Dyah Ika Krisnawati, Yung-Ching Liu, Yuarn-Jang Lee, Yun-Ting Wang, Chia-Ling Chen, Po-Chun Tseng, Ting-Jing Shen, Chiou-Feng Lin

    Published 2019-01-01
    “…The interferon- (IFN-) γ expression is elicited in response to microbial infections and activates immune surveillance by antimicrobial immune elements to induce microbial killing. …”
    Get full text
    Article
  17. 77
  18. 78

    Discovery of a non‐nucleotide stimulator of interferon genes (STING) agonist with systemic antitumor effect by Xiyuan Wang, Zhengsheng Zhan, Zhen Wang, Yan Zhang, Kaiyan Zhao, Han Li, Xiaoqian Zhou, Yuting Guo, Fengying Fan, Jian Ding, Meiyu Geng, Xuekui Yu, Wenhu Duan, Zuoquan Xie

    Published 2025-01-01
    “…Abstract Agonists of the stimulator of interferon genes (STING) pathway are increasingly being recognized as a promising new approach in the treatment of cancer. …”
    Get full text
    Article
  19. 79
  20. 80

    Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial) by Marina V. Mayevskaya, Ye. N. Bessonova, P. O. Bogomolov, N. I. Geyvandova, K. V. Zhdanov, V. G. Morozov, V. D. Pasechnikov, I. Yu. Khomenko, A. V. Yagoda, V. T. Ivashkin

    Published 2018-08-01
    “…Nowadays the question, whether pegylated interferon should be completely abandoned in the treatment of chronic hepatitis C (CHC) is still open. …”
    Get full text
    Article